IntraLase Schedules Fourth Quarter Conference Call for Thursday, February 16, 2006
February 09 2006 - 9:00AM
Business Wire
IntraLase Corp. (NASDAQ:ILSE) announced today that it will report
its 2005 fourth quarter and fiscal year-end results on Thursday,
February 16, 2006. A news release will be issued and will also be
posted on the company's website at www.intralase.com. Also on
February 16, IntraLase will hold an investor conference call at
11:00 a.m. Eastern Time to discuss the company's results. Hosting
the call will be Robert J. Palmisano, President and Chief Executive
Officer, and Shelley B. Thunen, Executive Vice President and Chief
Financial Officer. Members of the news media may "listen only" to
the conference call. The conference call will be webcast live and
can be accessed on the IntraLase website. The webcast is available
to both institutional and individual investors. Individual
investors can access the webcast at: www.fulldisclosure.com.
Institutional investors can access the webcast via a
password-protected event management site at www.streetevents.com.
The live call may also be accessed by telephone at (800) 561-2731
or for international parties at (617) 614-3528 and entering the
confirmation code 73779742 between 10:50 a.m. and 11:00 a.m.
Eastern Time. The webcast will be archived and available for replay
until 5:00 p.m. Pacific Time on February 23, 2006. A telephone
rebroadcast of the call may be accessed February 16, 2006 beginning
at 1:00 p.m. Eastern Time for a one-week period by calling (888)
286-8010 or for international parties (617) 801-6888 and entering
confirmation code 10068613. About IntraLase Corp IntraLase designs,
develops, and manufactures an ultra-fast laser that is
revolutionizing refractive and corneal surgery by creating safe and
more precise corneal incisions. Delivering on the promise of
ophthalmic laser technology, the IntraLase FS laser, related
software, and disposable devices replace the hand-held
microkeratome blade used during LASIK surgery. The unsurpassed
accuracy of IntraLase's computer-controlled femtosecond laser has
been shown to improve safety profiles and visual outcomes when used
during LASIK. Additionally, the IntraLase FS laser creates
precision-designed intracorneal incisions that when combined can be
used during lamellar and penetrating keratoplasties and
intrastromal ring implantation. IntraLase is presently in the
process of commercializing applications of its technology in the
treatment of corneal diseases that require corneal transplant
surgery. The company's proprietary laser and disposable patient
interfaces are presently marketed throughout the United States and
26 other countries. IntraLase is headquartered and manufactures its
products in Irvine, California. For additional information, visit
the company's web site: www.intralase.com.
Intralase (NASDAQ:ILSE)
Historical Stock Chart
From Jul 2024 to Aug 2024
Intralase (NASDAQ:ILSE)
Historical Stock Chart
From Aug 2023 to Aug 2024